PFE's Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal

• click to rate

  Posted by Two Blokes Jun 27 - Filed in Stock - 4 views
  
  Pfizer's Hympavzi meets key phase III goals, demonstrating a significant reduction in bleeding in hemophilia patients with inhibitors.